• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用机械化学合成路线制备环丙沙星-异烟酸共晶——关键工艺参数研究

Formation of Ciprofloxacin-Isonicotinic Acid Cocrystal Using Mechanochemical Synthesis Routes-An Investigation into Critical Process Parameters.

作者信息

Karimi-Jafari Maryam, Ziaee Ahmad, O'Reilly Emmet, Croker Denise, Walker Gavin

机构信息

Synthesis & Solid State Pharmaceutical Centre (SSPC), Department of Chemical Sciences, Bernal Institute, University of Limerick, V94 T9PX Limerick, Ireland.

出版信息

Pharmaceutics. 2022 Mar 13;14(3):634. doi: 10.3390/pharmaceutics14030634.

DOI:10.3390/pharmaceutics14030634
PMID:35336009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8949855/
Abstract

The mechanochemical synthesis of cocrystals has been introduced as a promising approach of formulating poorly water-soluble active pharmaceutical ingredients (APIs). In this study, hot-melt extrusion (HME) as a continuous process and grinding and ball milling as batch processes were employed to explore the feasibility of cocrystallization. Ciprofloxacin (CIP) and isonicotinic acid (INCA) were selected as the model API and coformer. CIP-INCA cocrystal was produced in all techniques. It was revealed that higher cocrystal content could be achieved at longer durations of grinding and ball milling. However, milling for more than 10 min led to increased co-amorphous content instead of cocrystal. A design of experiment (DoE) approach was used for deciphering the complex correlation of screw configuration, screw speed, and temperature as HME process parameters and their respective effect on final relative cocrystal yield. Statistical analysis showed that screw configuration, temperature, and their interaction were the most critical factors affecting cocrystallization. Interestingly, screw speed had minimal impact on the relative cocrystallization yield. Cocrystallization led to increased dissolution rate of CIP in phosphate buffer up to 2.5-fold. Overall, this study shed a light on the potential of mechanochemical synthesis techniques with special focus on HME as a continuous process for producing cocrystals.

摘要

共晶体的机械化学合成已被引入,作为一种配制难溶性活性药物成分(API)的有前景的方法。在本研究中,采用热熔挤出(HME)作为连续工艺,以及研磨和球磨作为间歇工艺,来探索共结晶的可行性。选择环丙沙星(CIP)和异烟酸(INCA)作为模型API和共形成剂。在所有技术中均制备出了CIP-INCA共晶体。结果表明,在较长的研磨和球磨时间下可获得更高的共晶体含量。然而,研磨超过10分钟会导致共无定形含量增加而非共晶体含量增加。采用实验设计(DoE)方法来解读作为HME工艺参数的螺杆配置、螺杆速度和温度之间的复杂关联,以及它们各自对最终相对共晶体产率的影响。统计分析表明,螺杆配置、温度及其相互作用是影响共结晶的最关键因素。有趣的是,螺杆速度对相对共结晶产率的影响最小。共结晶使CIP在磷酸盐缓冲液中的溶解速率提高了2.5倍。总体而言,本研究揭示了机械化学合成技术的潜力,特别关注HME作为生产共晶体的连续工艺。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5611/8949855/f96b8b127c21/pharmaceutics-14-00634-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5611/8949855/34eab7419ae6/pharmaceutics-14-00634-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5611/8949855/17d821c49984/pharmaceutics-14-00634-g0A2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5611/8949855/72a820b3ba4b/pharmaceutics-14-00634-g0A3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5611/8949855/463812bf9dde/pharmaceutics-14-00634-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5611/8949855/04a691434b5e/pharmaceutics-14-00634-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5611/8949855/a17ee8879937/pharmaceutics-14-00634-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5611/8949855/d55289c5fac0/pharmaceutics-14-00634-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5611/8949855/010b4d504155/pharmaceutics-14-00634-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5611/8949855/fe73637ecc73/pharmaceutics-14-00634-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5611/8949855/0219d499a98d/pharmaceutics-14-00634-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5611/8949855/e7f6239b4bcd/pharmaceutics-14-00634-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5611/8949855/2dcf8c264e3b/pharmaceutics-14-00634-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5611/8949855/047aa5eaeb60/pharmaceutics-14-00634-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5611/8949855/06a2504ab2e1/pharmaceutics-14-00634-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5611/8949855/6989acd77f6f/pharmaceutics-14-00634-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5611/8949855/f96b8b127c21/pharmaceutics-14-00634-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5611/8949855/34eab7419ae6/pharmaceutics-14-00634-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5611/8949855/17d821c49984/pharmaceutics-14-00634-g0A2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5611/8949855/72a820b3ba4b/pharmaceutics-14-00634-g0A3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5611/8949855/463812bf9dde/pharmaceutics-14-00634-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5611/8949855/04a691434b5e/pharmaceutics-14-00634-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5611/8949855/a17ee8879937/pharmaceutics-14-00634-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5611/8949855/d55289c5fac0/pharmaceutics-14-00634-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5611/8949855/010b4d504155/pharmaceutics-14-00634-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5611/8949855/fe73637ecc73/pharmaceutics-14-00634-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5611/8949855/0219d499a98d/pharmaceutics-14-00634-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5611/8949855/e7f6239b4bcd/pharmaceutics-14-00634-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5611/8949855/2dcf8c264e3b/pharmaceutics-14-00634-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5611/8949855/047aa5eaeb60/pharmaceutics-14-00634-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5611/8949855/06a2504ab2e1/pharmaceutics-14-00634-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5611/8949855/6989acd77f6f/pharmaceutics-14-00634-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5611/8949855/f96b8b127c21/pharmaceutics-14-00634-g013.jpg

相似文献

1
Formation of Ciprofloxacin-Isonicotinic Acid Cocrystal Using Mechanochemical Synthesis Routes-An Investigation into Critical Process Parameters.采用机械化学合成路线制备环丙沙星-异烟酸共晶——关键工艺参数研究
Pharmaceutics. 2022 Mar 13;14(3):634. doi: 10.3390/pharmaceutics14030634.
2
Continuous, one-step synthesis of pharmaceutical cocrystals via hot melt extrusion from neat to matrix-assisted processing - State of the art.热熔挤出从纯物质到基质辅助加工一步连续合成药物共晶 - 最新进展。
Int J Pharm. 2019 Mar 10;558:426-440. doi: 10.1016/j.ijpharm.2019.01.016. Epub 2019 Jan 18.
3
The role of the polymer matrix in solvent-free hot melt extrusion continuous process for mechanochemical synthesis of pharmaceutical cocrystal.聚合物基质在无溶剂热熔挤出连续工艺中用于机械化学合成药物共晶的作用。
Eur J Pharm Biopharm. 2018 Oct;131:48-59. doi: 10.1016/j.ejpb.2018.07.002. Epub 2018 Jul 3.
4
Mechanochemical Synthesis of Pharmaceutical Cocrystal Suspensions via Hot Melt Extrusion: Enhancing Cocrystal Yield.热熔挤出法制备药物共晶混悬剂的机械化学合成:提高共晶产率。
Mol Pharm. 2018 Sep 4;15(9):3741-3754. doi: 10.1021/acs.molpharmaceut.7b00979. Epub 2018 Jul 30.
5
Impact of polymeric excipient on cocrystal formation via hot-melt extrusion and subsequent downstream processing.聚合物辅料对热熔挤出及后续下游加工过程中共晶形成的影响。
Int J Pharm. 2019 Jul 20;566:745-755. doi: 10.1016/j.ijpharm.2019.06.031. Epub 2019 Jun 15.
6
Mechanochemical Synthesis of Pharmaceutical Cocrystal Suspensions via Hot Melt Extrusion: Feasibility Studies and Physicochemical Characterization.通过热熔挤出法进行药物共晶悬浮液的机械化学合成:可行性研究与物理化学表征
Mol Pharm. 2016 Sep 6;13(9):3054-68. doi: 10.1021/acs.molpharmaceut.6b00134. Epub 2016 Jul 26.
7
Tuning the cocrystal yield in matrix-assisted cocrystallisation via hot melt extrusion: A case of theophylline-nicotinamide cocrystal.热熔挤出法调控基质辅助共结晶中的共晶产率:茶碱-烟酰胺共晶的案例。
Int J Pharm. 2019 Oct 5;569:118579. doi: 10.1016/j.ijpharm.2019.118579. Epub 2019 Jul 27.
8
Mechanochemical Synthesis of Resveratrol-Piperazine Cocrystals.白藜芦醇 - 哌嗪共晶的机械化学合成
Materials (Basel). 2024 Jun 27;17(13):3145. doi: 10.3390/ma17133145.
9
Matrix-assisted cocrystallization (MAC) simultaneous production and formulation of pharmaceutical cocrystals by hot-melt extrusion.基质辅助共结晶(MAC):通过热熔挤出同时制备药物共晶体并进行制剂。
J Pharm Sci. 2014 Sep;103(9):2904-2910. doi: 10.1002/jps.23983. Epub 2014 May 7.
10
Creation of Hydrochlorothiazide Pharmaceutical Cocrystals Via Hot-Melt Extrusion for Enhanced Solubility and Permeability.通过热熔挤出技术制备氢氯噻嗪药物共晶以提高其溶解度和渗透性。
AAPS PharmSciTech. 2022 Jan 18;23(1):56. doi: 10.1208/s12249-021-02202-8.

引用本文的文献

1
Commentary: PLGA nanoparticles as an efficient carrier in GAP45: a more effective vaccine against acute toxoplasmosis than traditional ones.评论:聚乳酸-羟基乙酸共聚物纳米颗粒作为GAP45的有效载体:一种比传统疫苗更有效的抗急性弓形虫病疫苗。
Front Immunol. 2025 Aug 27;16:1663012. doi: 10.3389/fimmu.2025.1663012. eCollection 2025.
2
Process Development for the Continuous Manufacturing of Carbamazepine-Nicotinamide Co-Crystals Utilizing Hot-Melt Extrusion Technology.利用热熔挤出技术连续制造卡马西平-烟酰胺共晶体的工艺开发
Pharmaceutics. 2025 Apr 25;17(5):568. doi: 10.3390/pharmaceutics17050568.
3
The Benefits and Challenges of Antibiotics-Non-Steroidal Anti-Inflammatory Drugs Non-Covalent Reaction.

本文引用的文献

1
Pharmaceutical cocrystals: A review of preparations, physicochemical properties and applications.药物共晶体:制备、物理化学性质及应用综述
Acta Pharm Sin B. 2021 Aug;11(8):2537-2564. doi: 10.1016/j.apsb.2021.03.030. Epub 2021 Mar 23.
2
In Vitro Drug Release, Permeability, and Structural Test of Ciprofloxacin-Loaded Nanofibers.载环丙沙星纳米纤维的体外药物释放、渗透性及结构测试
Pharmaceutics. 2021 Apr 15;13(4):556. doi: 10.3390/pharmaceutics13040556.
3
Impact of polymeric excipient on cocrystal formation via hot-melt extrusion and subsequent downstream processing.
抗生素-非甾体抗炎药非共价反应的益处和挑战。
Molecules. 2023 Apr 23;28(9):3672. doi: 10.3390/molecules28093672.
聚合物辅料对热熔挤出及后续下游加工过程中共晶形成的影响。
Int J Pharm. 2019 Jul 20;566:745-755. doi: 10.1016/j.ijpharm.2019.06.031. Epub 2019 Jun 15.
4
Ciprofloxacin derivatives and their antibacterial activities.环丙沙星衍生物及其抗菌活性。
Eur J Med Chem. 2018 Feb 25;146:599-612. doi: 10.1016/j.ejmech.2018.01.078. Epub 2018 Feb 4.
5
Effect of ciprofloxacin on biological nitrogen and phosphorus removal from wastewater.环丙沙星对废水中生物脱氮除磷的影响。
Sci Total Environ. 2017 Dec 15;605-606:368-375. doi: 10.1016/j.scitotenv.2017.06.215. Epub 2017 Jun 29.
6
Development of a screening method for co-amorphous formulations of drugs and amino acids.药物与氨基酸共无定形制剂筛选方法的开发。
Eur J Pharm Sci. 2016 Dec 1;95:28-35. doi: 10.1016/j.ejps.2016.08.022. Epub 2016 Aug 13.
7
An analysis of the attrition of drug candidates from four major pharmaceutical companies.对四大制药公司候选药物淘汰的分析。
Nat Rev Drug Discov. 2015 Jul;14(7):475-86. doi: 10.1038/nrd4609. Epub 2015 Jun 19.
8
Pharmaceutical salts of ciprofloxacin with dicarboxylic acids.环丙沙星与二羧酸形成的药用盐
Eur J Pharm Sci. 2015 Sep 18;77:112-21. doi: 10.1016/j.ejps.2015.06.004. Epub 2015 Jun 9.
9
Nano-extrusion: a promising tool for continuous manufacturing of solid nano-formulations.纳米挤压:一种用于连续制造固体纳米制剂的有前景的工具。
Int J Pharm. 2014 Dec 30;477(1-2):1-11. doi: 10.1016/j.ijpharm.2014.10.008. Epub 2014 Oct 13.
10
Improving co-amorphous drug formulations by the addition of the highly water soluble amino Acid, proline.通过添加高水溶性氨基酸脯氨酸来改善共无定形药物制剂。
Pharmaceutics. 2014 Jul 14;6(3):416-35. doi: 10.3390/pharmaceutics6030416.